Literature DB >> 18559425

EspF Interacts with nucleation-promoting factors to recruit junctional proteins into pedestals for pedestal maturation and disruption of paracellular permeability.

Janneth Peralta-Ramírez1, J Manuel Hernandez, Rebeca Manning-Cela, José Luna-Muñoz, Carlos Garcia-Tovar, Jean-Philippe Nougayréde, Eric Oswald, Fernando Navarro-Garcia.   

Abstract

Many pathogenic bacteria subvert normal host cell processes by delivering effector proteins which mimic eukaryotic functions directly into target cells. EspF is a multifunctional protein injected into host cells by attaching and effacing pathogens, but its mechanism of action is not understood completely. In silico analyses of EspF revealed two key motifs: proline-rich domains and PDZ domain binding motifs. Such functional domains may allow EspF to act as an actin nucleation-promoting factor by mimicking host proteins. In agreement with these predictions, we found that EspF from rabbit enteropathogenic Escherichia coli (E22) participates in the regulation of actin polymerization by binding to a complex of proteins at the tight junctions (TJ). EspF bound to actin and profilin throughout the course of infection. However, after 2 h of infection, EspF also bound to the neural Wiskott-Aldrich syndrome protein and to the Arp2/3, zonula occludens-1 (ZO-1), and ZO-2 proteins. Moreover, EspF caused occludin, claudin, ZO-1, and ZO-2 redistribution and loss of transepithelial electrical resistance, suggesting that actin sequestration by EspF may cause local actin depolymerization leading to EspF-induced TJ disruption. Furthermore, EspF caused recruitment of these TJ proteins into the pedestals. An E22 strain lacking EspF did not cause TJ disruption and pedestals were smaller than those induced by the wild-type strain. Additionally, the pedestals were located mainly in the TJ. The overexpression of EspF caused bigger pedestals located along the length of the cells. Thus, actin sequestration by EspF allows the recruitment of junctional proteins into the pedestals, leading to the maturation of actin pedestals and the disruption of paracellular permeability.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18559425      PMCID: PMC2519440          DOI: 10.1128/IAI.00072-08

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  51 in total

1.  Enteropathogenic E. coli acts through WASP and Arp2/3 complex to form actin pedestals.

Authors:  D Kalman; O D Weiner; D L Goosney; J W Sedat; B B Finlay; A Abo; J M Bishop
Journal:  Nat Cell Biol       Date:  1999-10       Impact factor: 28.824

2.  Enteropathogenic Escherichia coli infection leads to appearance of aberrant tight junctions strands in the lateral membrane of intestinal epithelial cells.

Authors:  Michelle M Muza-Moons; Eveline E Schneeberger; Gail A Hecht
Journal:  Cell Microbiol       Date:  2004-08       Impact factor: 3.715

3.  Convergent and divergent ligand specificity among PDZ domains of the LAP and zonula occludens (ZO) families.

Authors:  Yingnan Zhang; Sherry Yeh; Brent A Appleton; Heike A Held; P Jaya Kausalya; Dominic C Y Phua; Wai Lee Wong; Laurence A Lasky; Christian Wiesmann; Walter Hunziker; Sachdev S Sidhu
Journal:  J Biol Chem       Date:  2006-05-31       Impact factor: 5.157

4.  EspF of enteropathogenic Escherichia coli binds sorting nexin 9.

Authors:  Oliver Marchès; Miranda Batchelor; Robert K Shaw; Amit Patel; Nicola Cummings; Takeshi Nagai; Chihiro Sasakawa; Sven R Carlsson; Richard Lundmark; Celine Cougoule; Emmanuelle Caron; Stuart Knutton; Ian Connerton; Gad Frankel
Journal:  J Bacteriol       Date:  2006-04       Impact factor: 3.490

Review 5.  The prevalence and significance of PDZ domain-phosphoinositide interactions.

Authors:  Pascale Zimmermann
Journal:  Biochim Biophys Acta       Date:  2006-04-27

6.  Actin depolymerization disrupts tight junctions via caveolae-mediated endocytosis.

Authors:  Le Shen; Jerrold R Turner
Journal:  Mol Biol Cell       Date:  2005-06-15       Impact factor: 4.138

7.  Role of tir and intimin in the virulence of rabbit enteropathogenic Escherichia coli serotype O103:H2.

Authors:  O Marchès; J P Nougayrède; S Boullier; J Mainil; G Charlier; I Raymond; P Pohl; M Boury; J De Rycke; A Milon; E Oswald
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

8.  A Rich1/Amot complex regulates the Cdc42 GTPase and apical-polarity proteins in epithelial cells.

Authors:  Clark D Wells; James P Fawcett; Andreas Traweger; Yojiro Yamanaka; Marilyn Goudreault; Kelly Elder; Sarang Kulkarni; Gerald Gish; Cristina Virag; Caesar Lim; Karen Colwill; Andrei Starostine; Pavel Metalnikov; Tony Pawson
Journal:  Cell       Date:  2006-05-05       Impact factor: 41.582

9.  Enteropathogenic Escherichia coli Tir translocation and pedestal formation requires membrane cholesterol in the absence of bundle-forming pili.

Authors:  Emma Allen-Vercoe; Barbara Waddell; Scott Livingstone; Julie Deans; Rebekah DeVinney
Journal:  Cell Microbiol       Date:  2006-04       Impact factor: 3.715

10.  Attaching and effacing pathogen-induced tight junction disruption in vivo.

Authors:  Julian A Guttman; Yuling Li; Mark E Wickham; Wanyin Deng; A Wayne Vogl; B Brett Finlay
Journal:  Cell Microbiol       Date:  2006-04       Impact factor: 3.715

View more
  23 in total

1.  The EspF effector, a bacterial pathogen's Swiss army knife.

Authors:  Ashleigh Holmes; Sabrina Mühlen; Andrew J Roe; Paul Dean
Journal:  Infect Immun       Date:  2010-08-02       Impact factor: 3.441

2.  The ability of an attaching and effacing pathogen to trigger localized actin assembly contributes to virulence by promoting mucosal attachment.

Authors:  Emily M Mallick; John J Garber; Vijay K Vanguri; Sowmya Balasubramanian; Timothy Blood; Stacie Clark; Didier Vingadassalom; Christopher Louissaint; Beth McCormick; Scott B Snapper; John M Leong
Journal:  Cell Microbiol       Date:  2014-06-02       Impact factor: 3.715

Review 3.  Targeting and alteration of tight junctions by bacteria and their virulence factors such as Clostridium perfringens enterotoxin.

Authors:  Miriam Eichner; Jonas Protze; Anna Piontek; Gerd Krause; Jörg Piontek
Journal:  Pflugers Arch       Date:  2016-11-18       Impact factor: 3.657

4.  Oral Administration with Live Attenuated Citrobacter rodentium Protects Immunocompromised Mice from Lethal Infection.

Authors:  Shuyu Wang; Xue Xia; Yue Liu; Fengyi Wan
Journal:  Infect Immun       Date:  2022-07-05       Impact factor: 3.609

Review 5.  Impact of enteric bacterial infections at and beyond the epithelial barrier.

Authors:  Ashleigh P Rogers; Steven J Mileto; Dena Lyras
Journal:  Nat Rev Microbiol       Date:  2022-09-29       Impact factor: 78.297

6.  The bacterial effectors EspG and EspG2 induce a destructive calpain activity that is kept in check by the co-delivered Tir effector.

Authors:  Paul Dean; Sabrina Mühlen; Sabine Quitard; Brendan Kenny
Journal:  Cell Microbiol       Date:  2010-03-25       Impact factor: 3.715

7.  The cytoskeletal scaffold Shank3 is recruited to pathogen-induced actin rearrangements.

Authors:  Alan Huett; John M Leong; Daniel K Podolsky; Ramnik J Xavier
Journal:  Exp Cell Res       Date:  2009-04-14       Impact factor: 3.905

8.  Calpain mediates epithelial cell microvillar effacement by enterohemorrhagic Escherichia coli.

Authors:  Yushuan Lai; Kathleen Riley; Andrew Cai; John M Leong; Ira M Herman
Journal:  Front Microbiol       Date:  2011-11-08       Impact factor: 5.640

9.  Invasiveness as a putative additional virulence mechanism of some atypical Enteropathogenic Escherichia coli strains with different uncommon intimin types.

Authors:  Denise Yamamoto; Rodrigo T Hernandes; Miguel Blanco; Lilo Greune; M Alexander Schmidt; Sylvia M Carneiro; Ghizlane Dahbi; Jesús E Blanco; Azucena Mora; Jorge Blanco; Tânia A T Gomes
Journal:  BMC Microbiol       Date:  2009-07-21       Impact factor: 3.605

Review 10.  Actin cytoskeleton manipulation by effector proteins secreted by diarrheagenic Escherichia coli pathotypes.

Authors:  Fernando Navarro-Garcia; Antonio Serapio-Palacios; Paul Ugalde-Silva; Gabriela Tapia-Pastrana; Lucia Chavez-Dueñas
Journal:  Biomed Res Int       Date:  2012-12-30       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.